rs199982439

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000264.5(PTCH1):​c.3804+32T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,612,168 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 8 hom. )

Consequence

PTCH1
NM_000264.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.00900

Publications

0 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-95449037-A-G is Benign according to our data. Variant chr9-95449037-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00233 (354/152086) while in subpopulation NFE AF = 0.00281 (191/67986). AF 95% confidence interval is 0.00248. There are 2 homozygotes in GnomAd4. There are 168 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 354 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH1NM_000264.5 linkc.3804+32T>C intron_variant Intron 22 of 23 ENST00000331920.11 NP_000255.2 Q13635-1
PTCH1NM_001083603.3 linkc.3801+32T>C intron_variant Intron 22 of 23 ENST00000437951.6 NP_001077072.1 Q13635-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH1ENST00000331920.11 linkc.3804+32T>C intron_variant Intron 22 of 23 5 NM_000264.5 ENSP00000332353.6 Q13635-1
PTCH1ENST00000437951.6 linkc.3801+32T>C intron_variant Intron 22 of 23 5 NM_001083603.3 ENSP00000389744.2 Q13635-2

Frequencies

GnomAD3 genomes
AF:
0.00232
AC:
353
AN:
151968
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.00227
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00303
AC:
751
AN:
247796
AF XY:
0.00314
show subpopulations
Gnomad AFR exome
AF:
0.000445
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.0170
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00270
Gnomad NFE exome
AF:
0.00358
Gnomad OTH exome
AF:
0.00428
GnomAD4 exome
AF:
0.00277
AC:
4049
AN:
1460082
Hom.:
8
Cov.:
31
AF XY:
0.00284
AC XY:
2065
AN XY:
725936
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33460
American (AMR)
AF:
0.00224
AC:
100
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0174
AC:
454
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39636
South Asian (SAS)
AF:
0.000383
AC:
33
AN:
86230
European-Finnish (FIN)
AF:
0.00238
AC:
127
AN:
53270
Middle Eastern (MID)
AF:
0.00885
AC:
51
AN:
5760
European-Non Finnish (NFE)
AF:
0.00276
AC:
3064
AN:
1110588
Other (OTH)
AF:
0.00345
AC:
208
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
230
460
690
920
1150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00233
AC:
354
AN:
152086
Hom.:
2
Cov.:
33
AF XY:
0.00226
AC XY:
168
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.000482
AC:
20
AN:
41482
American (AMR)
AF:
0.00223
AC:
34
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
73
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4804
European-Finnish (FIN)
AF:
0.00227
AC:
24
AN:
10576
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00281
AC:
191
AN:
67986
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00427
Hom.:
0
Bravo
AF:
0.00229
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gorlin syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.8
DANN
Benign
0.70
PhyloP100
0.0090
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199982439; hg19: chr9-98211319; API